MES and APM: A Natural Partnership
The pharmaceutical industry operates at the intersection of manufacturing complexity and regulatory rigour. Assets must perform reliably and precisely — because batch failures don't just cost money, they potentially harm patients. Manufacturing Execution Systems (MES) have become a critical part of the pharmaceutical manufacturing landscape, managing the execution of production processes from batch recipe to batch record. But can MES also contribute to Asset Performance Management (APM)?
What Is a Manufacturing Execution System?
A MES is a software system that manages and controls the manufacturing process in real time, bridging the gap between enterprise planning (ERP) and shop floor control (SCADA/DCS). In pharmaceuticals, MES typically manages batch execution, electronic batch records, material management, quality management, and equipment management — including equipment status tracking, calibration management, and cleaning records.
The APM Connection
The link between MES and APM lies in data. MES systems accumulate rich operational data about how equipment is being used: cycle counts, operating conditions, batch frequencies, cleaning cycles, and any deviations from standard operating parameters. This data has significant value for asset performance management when it's connected to the maintenance and reliability domain.
Equipment Usage Tracking
MES data enables usage-based maintenance triggers — scheduling calibration, cleaning validation, or preventive maintenance based on actual usage cycles rather than arbitrary calendar intervals. This is particularly valuable in pharmaceutical manufacturing, where maintenance activities must be documented and justified to regulatory standards.
Failure Mode Context
When equipment failures occur during batch execution, MES records provide invaluable context for root cause analysis: what was the equipment doing at the time of failure, what process parameters were in play, and what was the sequence of events preceding the failure? This context dramatically improves the quality of failure analysis.
Batch Record Traceability
Connecting MES batch records to maintenance records enables investigators to assess whether asset condition may have contributed to batch failures or quality deviations — a critical capability for 21 CFR Part 11 compliance and FDA audit readiness.
Implementing the Integration
Realising this value requires both technical integration (connecting MES data to the CMMS or APM platform) and process integration (ensuring that maintenance and quality teams use the shared data effectively). Optimal has experience in both dimensions, helping pharmaceutical clients build integrated asset intelligence capabilities that improve both compliance and operational performance.
Ready to apply these insights? Contact Optimal at enquiries@optimal.world or book a discovery call to speak with one of our experts.